Antidiabetogenic effect of glucagon-like peptide-1 (736)amide in normal subjects and patients with diabetes mellitus
Unopened pens should be stored in the refrigerator at 36F to 46F (2C to 8C) and should never be frozen
Acute kidney injury can develop if fluid losses are not replaced, particularly during prolonged vomiting, diarrhoea, or reduced fluid intake
Back in 2018, most of its earnings came from generics, with only a small share driven by innovation. Between 2025 and 2027, the company expects to bring dozens of major breakthroughs to market from GLP-1 therapies for obesity and diabetes to next-generation oncology treatments. Source: *Opinions are my own To view or add a comment, sign in Big Pharma News: Pfizer is set to acquire Metsera in a deal worth up to $4.9B Why it matters: $47.50/share upfront + $22.50/share tied to milestones Lead candidate MET-097i (GLP-1 therapy) showed 11.3% weight loss in 12 weeks Pipeline includes monthly amylin-based injections + oral obesity drugs Puts Pfizer head-to-head with Lilly & Novo Nordisk in the obesity race This move highlights the booming obesity drug market and pharmas growing appetite for metabolic innovation
The amount of weight you can lose with Ozempic varies depending on your individual health, lifestyle, and dosage prescribed by your healthcare provider
Do not exceed the recommended dose Company Information Ask for more detail from the seller Contact Supplier